On July 30, INNOVENT BIO declined 3.12% in regular trading, trading at 86.8 HKD/share, with turnover of HKD 405 million.
Within the Biotechnology sector where INNOVENT BIO belongs, the overall sector is under broad selling pressure. Among individual stocks, AKESO down 2.56%, BEIGENE down 2.31%, 3SBIO down 2.29%, SKB BIO down 4.62%, REMEGEN down 4.77%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)